Eduardo Vilar
Oncology · 2010
A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 11 citations into it
- Pathology and Forensic Medicine — 10 citations into it
- Molecular Biology — 8 citations into it
Whom Eduardo Vilar trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Eduardo Vilar's perspective
Ordered by how strongly the researchers Eduardo Vilar trusts endorse each paper. Same corpus, a different order for every researcher.
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancer (Nature Reviews. Cancer)
- Topoisomerase I inhibitors: camptothecins and beyond (Nature Reviews. Cancer)
- Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. (Journal of the National Cancer Institute)
- Genome maintenance mechanisms for preventing cancer (Nature)
- Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). (New England Journal of Medicine)
- Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. (New England Journal of Medicine)
- Mutations of the BRAF gene in human cancer (Nature)
- High Frequency of Mutations of the PIK3CA Gene in Human Cancers (Science)
- Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. (New England Journal of Medicine)
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy (Nature)
Their papers
- Microsatellite instability in colorectal cancer—the stable evidence (2010) — 999 citations